This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit May 28, 2015
Advertisement
   NAMCP Medical Directors Institute   AAMCN    AAIHDS    Conferences    JMCM    Contact Us  

Check out JMCM’s new website at www.jmcmpub.org

We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!

We wanted you to be aware that FDA-approved Hysingla™ ER (hydrocodone bitartrate) extended-release tablets CII has commercially launched in the U.S. Please click here to view the press release.

Click here for a CME/CEU activity on Improving Treatment of Atrial Fibrillation and Stoke

Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.

Click here to view our Complimentary Online CME/CEU Webcasts

OAs part of APhA's longstanding and ongoing commitment to helping its members ensure optimal and safe patient use of prescription medications, nonprescription products, and dietary supplements, APhA convened national pharmacy and medicine leaders and other stakeholders on March 26. Click here for more information .

 

Fall Managed Care Forum: Register today!
NAMCP

Register today for the 2015 Fall Forum being held November 12-13, 2015 at The Bellagio in Las Vegas. Click here to visit the conference website.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




GENOMICS


Scientists give yeast human genes to show how much we have in common
The Washington Post
It's been a billion years since we shared a common ancestor, but yeast — a simple, single-celled fungus — is still a distant cousin on our family tree. In fact, even this distant relation has enough in common with us to swap out genes and survive. In a study in Science, researchers report successfully swapping out some 450 of the genes in baker's yeast with similar ones from a human.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Infidelity lurks in your genes
The New York Times
Americans disapprove of marital infidelity. Ninety-one percent of them find it morally wrong, more than the number that reject polygamy, human cloning or suicide, according to a 2013 Gallup poll. Yet the number of Americans who actually cheat on their partners is rather substantial: Over the past two decades, the rate of infidelity has been pretty constant at around 21 percent for married men, and between 10 to 15 percent for married women,.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Link found between breast cancer genes, prostate cancer
The Wall Street Journal
Mutations in two genes well known for increasing the risk of breast and ovarian cancer may also play an important role in advanced prostate cancer, researchers said, an unexpected discovery that could lead to new treatments for some men with the disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


Using companion diagnostics to find the right drug for the right person at the right time
Forbes
The term “personalized medicine” is frequently added to the discussions of how to improve healthcare, and a new breed of medical devices called companion diagnostics are much of the backbone for this new approach to personalized care.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Measure, Monitor Immunoglobulin Treatment Outcomes
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.

Request more information or schedule a personal introduction.
 


Precision medicine is 'personalized, problematic and promising'
Medical Xpress
The rapidly emerging field of precision medicine is a "disruptive innovation" that offers the possibility of remarkably fine-tuned remedies to improve patient health while minimizing the risk of harmful side effects, says J. Larry Jameson, M.D., Ph.D., dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System, in the New England Journal of Medicine.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


Study: Stem cells can be safely infused in brain to promote stroke recovery
Fox News
A yearlong study of stroke patients has found that stem cells from a patient’s bone marrow can be safely infused in the brain through the carotid artery to promote recovery. Researchers at the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine followed 48 patients, more than half of whom who were treated using stem cells, and found recovery along with no adverse side effects when compared with their counterparts.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




How Minecraft players are funding stem cell research
TIME
Online video game streaming service Twitch is hosting a 24-hour Minecraft marathon to benefit the National Stem Cell Foundation. Saturday, June 6 charity marathon, called Reason2Play, is slated to feature top Minecraft players.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


EMERGING MEDICAL TECHNOLOGIES


Novartis digs into health tech with bet on 'robotic pill'
Reuters
Swiss drugmaker Novartis is raising its bet on smart technology by collaborating with U.S. start-up Rani Therapeutics on a “robotic pill” for complex biotech drugs that would normally have to be given by injection. Rani said it would run feasibility studies over the next 18-24 months to evaluate how selected Novartis biologic medicines can be delivered into the bloodstream using its unique device.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
SOAPware. Exceptional Software. Empowering Healthcare.
Ranked #1 in the Nation for Quality of Care. Our Meaningful Use certified software is designed by medical providers, making SOAPware the preferred EHR for medical professionals! MORE
Advertise here!

To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


ACCOUNTABLE CARE ORGANIZATIONS


To succeed long-term, ACOs must increase consumer focus
FierceHealthcare
The accountable care organization model has seen substantial progress in recent years, but to succeed in the long term, the Next Generation ACO model must provide comprehensive data and engage with consumers, 12 consumer advocacy groups said in a letter to the Centers for Medicare & Medicaid Services.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The 4 must-win health IT objectives of ACOs
Healthcare IT News
When Donald Berwick and the Institute for Healthcare Improvement launched the Triple Aim initiative in 2008, they envisioned a framework for optimizing health system performance by simultaneously focusing on the health of a population, the experience of care for individuals within that population, and the per capita cost of providing that care.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


FDA ticks off 1st drug to treat radiation sickness after nuclear disasters
Gizmag
A drug long-used to counter the negative effects of chemotherapy has won U.S. Food and Drug Administration approval for use in treating the nasty effects of exposure to radiation following a nuclear disaster. Known commercially as neupogen, the drug has been shown to work by shielding the body's white blood cells to heighten a patient's chances of survival.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA poised to phase out artery-clogging fat
NPR
The case against trans fats is not new. For years, health experts have been telling us to avoid them. And as retailing behemoths such as Wal-Mart have committed to the removal of all remaining, industrially produced trans fats in the products they sell, the food industry has stepped up its pace to reformulate its offerings.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MANAGED HEALTHCARE NEWS


Ignoring the penalty for not buying health insurance
The New York Times
Obamacare’s big stick doesn’t seem to be scaring many people into buying health insurance. The health law includes many inducements for people to obtain health insurance — including free Medicaid coverage for many low-income Americans and subsidies for those with moderate incomes. But it also includes the notorious “individual mandate,” a fine for those who can afford insurance but don’t buy it.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


5 reasons your health insurance premium will likely rise in 2016
The Motley Fool
It's been a little over a year since the Patient Protection and Affordable Care Act was officially implemented and U.S. citizens were required to purchase health insurance or face a penalty come tax time. The goals of this healthcare reform law, which you probably know better as Obamacare, are twofold.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    US introduces new DNA standard for ensuring accuracy of genetic tests (The New York Times)
Do mosquitoes love you? Maybe blame your genes (The Dallas Morning News)
Early bird or night owl? It could be in your genes (CNET)
Fall Managed Care Forum: Register today! (NAMCP)
Cystic fibrosis drug wins approval of FDA advisory panel (The New York Times)

Don't be left behind. Click here to see what else you missed.
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
May 21, 2015
May 14, 2015
May 7, 2015
April 30, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063